Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $1.2 billion.

  • Dexcom's Receivables - Net rose 2105.63% to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year increase of 2105.63%. This contributed to the annual value of $1.2 billion for FY2025, which is 2105.63% up from last year.
  • Dexcom's Receivables - Net amounted to $1.2 billion in Q4 2025, which was up 2105.63% from $1.1 billion recorded in Q3 2025.
  • Dexcom's Receivables - Net's 5-year high stood at $1.3 billion during Q2 2025, with a 5-year trough of $443.4 million in Q1 2021.
  • Moreover, its 5-year median value for Receivables - Net was $768.2 million (2023), whereas its average is $815.2 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first soared by 6306.91% in 2021, then soared by 322.42% in 2024.
  • Quarter analysis of 5 years shows Dexcom's Receivables - Net stood at $519.7 million in 2021, then surged by 38.66% to $720.6 million in 2022, then soared by 36.44% to $983.2 million in 2023, then rose by 3.22% to $1.0 billion in 2024, then rose by 21.06% to $1.2 billion in 2025.
  • Its Receivables - Net was $1.2 billion in Q4 2025, compared to $1.1 billion in Q3 2025 and $1.3 billion in Q2 2025.